MZL

Clinical trials for MZL explained in plain language.

Never miss a new study

Get alerted when new MZL trials appear

Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3

Promising combo aims to shrink lymphoma without chemo

Disease control Recruiting now

This study tests whether combining rituximab (an antibody) with venetoclax (a targeted pill) can effectively treat marginal zone lymphoma that hasn't been treated before. About 33 adults with measurable disease will receive the drug combo, and researchers will measure how many ac…

Matched conditions: MZL

Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

MZL

Get alerted when new MZL trials appear

Promising combo aims to shrink lymphoma without chemo